June 3, 2020: On February eleven, 2020, HHS issued a message (PDF, 162 KB) to point out stakeholders Keeping antiviral drug items (Tamiflu and Relenza) about supplemental expiry dating extensions for appropriately held product or service. “…Depending on FDA's critique of scientific information, FDA has concluded for emergency responses that, https://remingtonwgpwc.angelinsblog.com/32264872/a-review-of-expired-listing-campaign